Alibaba
BABA
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
Apple
AAPL
US Stock MarketDetailed Quotes
RSLS ReShape Lifesciences
- 2.3300
- -0.2100-8.27%
Close Feb 14 16:00 ET
- 2.3300
- 0.00000.00%
Post 19:43 ET
1.70MMarket Cap-0.23P/E (TTM)
2.5868High2.3200Low124.18KVolume2.5700Open2.5400Pre Close307.52KTurnover17.94%Turnover RatioLossP/E (Static)729.98KShares29.000052wk High1.14P/B1.61MFloat Cap2.320052wk Low--Dividend TTM692.17KShs Float4647888000.0000Historical High--Div YieldTTM10.50%Amplitude2.3200Historical Low2.4760Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
ReShape Lifesciences Stock Forum
5 MINUTES AGO, 8:31 AM EST
VIA GLOBENEWSWIRE
ReShape Lifesciences (RSLS) reported Q3 2024 financial results, showing revenue growth of 16.6% over Q2 2024 and 6.4% year-over-year to $2.3 million.
The company achieved a 40.6% reduction in operating expenses for the first nine months of 2024 compared to 2023.
Gross profit margin improved to 62.8% in Q3 2024.
The company entered into a merger agreement with Vyome Therapeutics and an asset purchase agreement with Biorad Medisys for $5.16 million.
ReSha...
ReShape Lifesciences: Entered Into Merger Agreement With Vyome Therapeutics & Asset Purchase Agreement With Biorad Medisys
4 mins ago
ReShape Lifesciences® Receives Health Canada Approval for Its Next-Generation Lap-Band® 2.0 Flex
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
ReShape Lifesciences (Nasdaq: RSLS) has received Health Canada approval for its next-generation Lap-Band® 2.0 FLEX and Tubing Kit. The enhanced device features new Flex technology that acts as a relief valve, allowing larger food pieces to pass through more easily by temporarily relaxing before returning to its resting diameter. Like its predecessor, the device can...
No comment yet